Berlin-based REMATIQ, an AI-native platform for automated product compliance in MedTech, has raised €5.4 million in a Seed funding spherical to develop its AI expertise, increase its engineering crew, and drive progress throughout Europe and the U.S.
The spherical is led by Undertaking A Ventures, with participation from Amino Collective and HelloWorld, and complemented by enterprise angels equivalent to SaaS founder Boris Lokschin (Spryker Methods) and business veteran Timo Fleßner.
“Regulatory necessities shouldn’t decelerate innovation – they need to assist speed up it. With REMATIQ, we flip compliance from a hurdle right into a aggressive benefit,” says David Boutellier, Co-founder & CEO of REMATIQ. “Our purpose is to carry life-saving MedTech options – from wound care to CT scanners – to sufferers sooner. We’re grateful to our buyers for believing on this imaginative and prescient and supporting us in reshaping the business.”
REMATIQ was based in 2023 by David Boutellier and Florian Scherer. They consider that regulatory necessities are important—however they need to by no means maintain again innovation. With REMATIQ, they give the impression of being to assist MedTech corporations scale back regulatory complexity with out sacrificing high quality or security.
The platform makes use of AI to simplify compliance workflows throughout medical machine improvement. It interprets laws – like MDR and FDA – into structured, actionable necessities and integrates them into corporations’ current methods. This reportedly saves as much as 90% of the time usually required for regulatory documentation and coordination – liberating up engineers to concentrate on probably life-changing improvements.
In line with REMATIQ, regulatory necessities are among the many greatest challenges within the MedTech business: greater than 40% of R&D groups’ time is spent on guide regulatory duties – time that might be used for innovation.
REMATIQ’s AI-powered platform analyses world regulatory paperwork and supplies actionable necessities. These are built-in instantly into improvement and high quality processes, reportedly lowering documentation efforts by as much as 90% and considerably reducing the danger of non-compliance.
“The amount and complexity of worldwide laws proceed to develop. We really feel this daily – in improvement, medical analysis, regulatory approval, and post-market surveillance. An AI-based method to regulatory necessities administration – just like the one REMATIQ presents – addresses precisely the purpose of highest leverage,” says Mandy Blocher, Head of PLM Digitalization & Regulatory Intelligence on the B. Braun Group.
REMATIQ plans to make use of the brand new capital to additional develop its AI expertise, increase its engineering crew, and drive worldwide progress throughout Europe and the USA.
Anton Waitz, Basic Accomplice at Undertaking A, provides: “REMATIQ is fixing a mission-critical downside. Whereas regulatory burdens are slowing many corporations down, REMATIQ presents a strategy to dramatically improve effectivity – with out compromising on high quality or security. The crew impressed us with deep business experience and a powerful expertise imaginative and prescient. We’re excited to assist them on this journey.“
